...
首页> 外文期刊>Ophthalmology >Transretinal choroidal tumor biopsy with a 25-gauge vitrector.
【24h】

Transretinal choroidal tumor biopsy with a 25-gauge vitrector.

机译:经25线玻璃体切变的视网膜脉络膜肿瘤活检。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: To describe and evaluate transretinal biopsy of choroidal tumors using 25-gauge vitrectomy instrumentation. DESIGN: Retrospective, consecutive, noncomparative case series. PARTICIPANTS: Fourteen patients undergoing choroidal tumor biopsy at an ocular oncology center. METHODS: The biopsies were performed under local or general anesthesia, alone or in combination with ruthenium plaque or tantalum marker insertion. Immunohistochemistry was performed on all samples, and some melanomas were also analyzed cytogenetically. RESULTS: Surgery was uneventful in all cases. A positive tissue diagnosis was made in 13 of 14 patients, albeit at the second attempt in 1 patient. The only failure occurred because the tumor was calcified. CONCLUSION: Transretinal choroidal biopsy with 25-gauge instrumentation yields a larger sample than fine-needle aspiration biopsy, usually producing sufficient tissue for cytogenetic studies. We did not identify safety concerns in this series of patients. Insufficient samples can occur in some patients, and further studies are needed to understand the reason for such failure.
机译:目的:描述和评估使用25规格玻璃体切除术对脉络膜肿瘤进行的视网膜穿刺活检。设计:回顾性,连续性,非对比性案例系列。对象:在眼肿瘤中心接受脉络膜肿瘤活检的十四名患者。方法:活检在局部或全身麻醉下进行,单独或与钌斑块或钽标记物插入结合进行。对所有样品进行免疫组织化学,并且还对一些黑色素瘤进行了细胞遗传学分析。结果:所有病例手术均顺利。尽管有1位患者进行了第二次尝试,但14位患者中有13位诊断为阳性。唯一的失败是因为肿瘤被钙化。结论:25针仪器经视网膜脉络膜活检可比细针穿刺活检产生更大的样本,通常可为细胞遗传学研究提供足够的组织。我们没有在这一系列患者中发现安全隐患。在某些患者中可能会出现样本不足的情况,需要进一步研究以了解此类失败的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号